Torticollis: Clinical Trials

13 trials for Torticollis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed. 13 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 313Completed 13

Follow Torticollis: new trials by email Literature Review of Torticollis trials Research Report on Torticollis

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia
Neuronox(R), Dysport (R) - Cervical Dystonia
Phase 3CompletedDepartment of Medical Services Ministry of Public Health of Thailand522019-10-252021-03-09
Neubotulinum Toxin Injection in Cerivical Dystonia
Neuronox ® Injection - Cervical Dystonia
Phase 3CompletedDepartment of Medical Services Ministry of Public Health of Thailand502019-01-032021-09-17
Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)
daxibotulinumtoxinA for injection - Cervical Dystonia
Phase 3CompletedRevance Therapeutics, Inc.3572018-09-052022-01-28
Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)
DaxibotulinumtoxinA for injection, Placebo - Cervical Dystonia
Phase 3CompletedRevance Therapeutics, Inc.3012018-06-202022-12-05
Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia
Botulinum toxin type A - Cervical Dystonia
Phase 3CompletedIpsen1122013-03-012019-08-07
Efficacy and Safety of MEDITOXIN® in Cervical Dystonia
Medytoxin, Botox - Cervical Dystonia
Phase 3CompletedMedy-Tox1522013-01-092019-04-08
Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.
Botulinum toxin type A, Placebo - Cervical Dystonia
Phase 3CompletedIpsen1342013-01-012019-08-07
Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia
Botulinum toxin type A, Placebo - Cervical Dystonia
Phase 3CompletedIpsen3822011-04-012022-09-28
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia
incobotulinumtoxinA (Xeomin) (240 Units), incobotulinumtoxinA (Xeomin) (120 Units), Placebo - Cervical Dystonia
Phase 3CompletedMerz Pharmaceuticals GmbH2332006-07-012013-07-19
Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
Botulinum toxin type A - Cervical Dystonia
Phase 3CompletedIpsen1082006-02-012022-09-28
Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
Botulinum toxin type A, Placebo - Cervical Dystonia
Phase 3CompletedIpsen1162005-10-102022-09-28
Double-blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients With Medically Refractory Primary Cervical Dystonia
Deep brain stimulation (DBS) - Cervical Dystonia
Phase 3CompletedGerman Parkinson Study Group (GPS)632005-07-012018-02-19
Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia
Botulinum toxin type A - Cervical Dystonia
Phase 3CompletedIpsen5162004-10-012023-03-30

Broader conditions

Dyskinesias (13)  ·  Dystonia (13)  ·  Neurologic Manifestations (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Signs and Symptoms (13)

Interventions

Botulinum Toxins, Type A (10)  ·  abobotulinumtoxinA (7)  ·  Injections (2)  ·  Deep Brain Stimulation (1)  ·  Injections, Intramuscular (1)  ·  incobotulinumtoxinA (1)

Sponsors

Ipsen (6)  ·  Department of Medical Services Ministry of Public Health of Thailand (2)  ·  Revance Therapeutics, Inc. (2)  ·  German Parkinson Study Group (GPS) (1)  ·  Medy-Tox (1)  ·  Merz Pharmaceuticals GmbH (1)

Countries

United States (7)  ·  Austria (5)  ·  Germany (5)  ·  Czechia (3)  ·  France (3)  ·  Poland (3)  ·  Russia (3)  ·  Canada (2)  ·  Spain (2)  ·  Thailand (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Belgium (1)  ·  Hungary (1)  ·  Portugal (1)

Top investigators

Cynthia Comella, M.D. (1)  ·  Joerg Mueller, MD (1)  ·  Subsai Kongsaengdao (1)

Results publications

PMID 20359934, PMID 25324317, PMID 21764407, PMID 22021883, PMID 23604344, PMID 23779062, PMID 25127231, PMID 26074391, PMID 27653448, PMID 28138245, PMID 29731634, PMID 32884828, PMID 33524060, PMID 38295339, PMID 40439027

NIH funding

2005 (2), 2004 (1)